Stocks Health care NAII
NASDAQ · Health careNatural Alternatives International Inc (NAII)
Natural Alternatives International Inc brought in $141.9M of revenue over the twelve months to March 31, 2026, up 13.1% from a year earlier. It posted a net loss of $14.4M. Operating cash flow minus capital spending left $2.3M of free cash flow in fiscal 2025. At March 31, 2026 it held $9.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 19, 2026.
Watch NAII in 60 secondsWhat Natural Alternatives International Inc does
Natural Alternatives International Inc is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker NAII.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $129.9M | -$13.6M | -$2.28 | $2.3M |
| 2024 | $113.8M | -$7.2M | -$1.23 | -$4.5M |
| 2023 | $154M | $2.5M | $0.43 | -$6.5M |
| 2022 | $171M | $10.7M | $1.74 | -$14.6M |
| 2021 | $178.5M | $10.8M | $1.69 | $15.7M |
| 2020 | $118.9M | -$1.6M | -$0.25 | -$850K |
Full financial statements: income, balance sheet and cash flow
Where NAII ranks in Health care
Latest SEC filings
What Natural Alternatives International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- May 21, 2026
- May 19, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 23% to $35.5M versus the same quarter last year; diluted EPS -$0.72 versus -$0.37.
- May 18, 2026Late quarterly report notice NT 10-Q
- May 1, 2026
- March 20, 2026
- February 13, 2026Quarterly report 10-Q · period to December 31, 2025Revenue rose 2.1% to $34.8M versus the same quarter last year; diluted EPS -$0.42 versus -$0.37.
- January 21, 2026Passive stake changed SCHEDULE 13G/A
- December 17, 2025
- December 12, 2025
- November 12, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 14% to $37.7M versus the same quarter last year; diluted EPS -$0.05 versus -$0.33.
What is NAII worth? A DCF from its reported cash flow
Who owns NAII
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Joseph F. Helmer13G, passive with 1 related filers | 7.8% | February 11, 2025 |
| Dimensional Fund Advisors LP13G, passive | 6.2% | January 21, 2026 |
Largest institutional holders
Insiders
Questions about NAII
What does Natural Alternatives International Inc do?
Natural Alternatives International Inc is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker NAII.
Is Natural Alternatives International Inc profitable?
No. Over the twelve months to March 31, 2026 it reported a net loss of $14.4M on revenue of $141.9M.
How much revenue does Natural Alternatives International Inc make?
Over the twelve months to March 31, 2026 Natural Alternatives International Inc reported revenue of $141.9M. That is 13.1% more than a year earlier.
When did Natural Alternatives International Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 19, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the employee stock plan registration from May 21, 2026.
Similar companies
Compare NAII with
Follow NAII
Get an email when Natural Alternatives International Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow NAII: get an email when it filesWhere the numbers come from
Financial figures are the values Natural Alternatives International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.